These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28947238)

  • 1. Cancer as an ecomolecular disease and a neoplastic consortium.
    Ramón Y Cajal S; Capdevila C; Hernandez-Losa J; De Mattos-Arruda L; Ghosh A; Lorent J; Larsson O; Aasen T; Postovit LM; Topisirovic I
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):484-499. PubMed ID: 28947238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
    Du W; Elemento O
    Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):286-92. PubMed ID: 23792107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microcosmos of intratumor heterogeneity: the space-time of cancer evolution.
    Janiszewska M
    Oncogene; 2020 Mar; 39(10):2031-2039. PubMed ID: 31784650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The origins of cancer robustness and evolvability.
    Tian T; Olson S; Whitacre JM; Harding A
    Integr Biol (Camb); 2011 Jan; 3(1):17-30. PubMed ID: 20944865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
    Capp JP
    Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
    Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
    Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
    Nissinen L; Farshchian M; Riihilä P; Kähäri VM
    Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.
    Escargueil AE; Prado S; Dezaire A; Clairambault J; Larsen AK; Soares DG
    Curr Pharm Des; 2016; 22(44):6625-6644. PubMed ID: 27587198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer: A turbulence problem.
    Uthamacumaran A
    Neoplasia; 2020 Dec; 22(12):759-769. PubMed ID: 33142240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance.
    Chiavarina B; Turtoi A
    Curr Med Chem; 2017; 24(26):2846-2859. PubMed ID: 28462708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
    Beckman RA; Schemmann GS; Yeang CH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecological photodynamic therapy: new trend to disrupt the intricate networks within tumor ecosystem.
    Rumie Vittar NB; Lamberti MJ; Pansa MF; Vera RE; Rodriguez ME; Cogno IS; Milla Sanabria LN; Rivarola VA
    Biochim Biophys Acta; 2013 Jan; 1835(1):86-99. PubMed ID: 23127970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor microenvironment: promising therapeutic target].
    Kawasaki Y; Akiyama T
    Nihon Rinsho; 2015 Aug; 73(8):1283-7. PubMed ID: 26281679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.